BRIACELL THERAPEUTICS CORP. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
BRIACELL THERAPEUTICS CORP. (BCTX) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 10.05 million shares for the 12-month period ending 2022-07-31, per its 10-K filed 2022-10-28.
Discontinued › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2022-10-28
- BRIACELL THERAPEUTICS CORP. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 10.05M shares, a 2687.12% increase from fiscal 2021.
- BRIACELL THERAPEUTICS CORP. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2021 was 360.76K shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|
| 2022-07-31 | 10.05M shares 10-K · filed 2022-10-28 |
| 2021-07-31 | 360.76K shares 10-K · filed 2022-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |